Navigation Links
Little-known protein found to be key player
Date:7/29/2009

ly development. They also created mutant versions of the protein to see how it functioned -- or failed to function -- when some parts were disabled.

The tests showed that cells with extra atlastin had an overdeveloped endoplasmic reticulum (ER), a system of interconnected membrane tubes and chambers that's critical for normal cell function. The tests also showed too little atlastin led to a fragmented ER. Flies with defective atlastin were sterile and short-lived.

"The endoplasmic reticulum is an ever-changing environment," McNew said. "It grows. It retracts. It expands. It collapses. It's highly dynamic, and for that to be the case, there has to be a mechanism by which it can grow new pieces and connect those pieces together. That's where the fusion comes in."

Daga said the discovery will lay the foundation for a deeper understanding of both basic biological processes and disease.

"We hope the findings lead to a better understanding of hereditary spastic paraplegia (HSP), the genetic disorder that atlastin has been linked with," Daga said.

HSP is a rare genetic condition that affects fewer than one million people worldwide. It's marked by a partial paralysis of the lower extremities due to defects in the body's longest cells, the neurons that run from the spine through the legs.

Daga said atlastin's role in building and maintaining a healthy ER may help HSP researchers better understand why neurons are affected first.

"This is the first clue," Daga said. "We have the definition of what the protein does. Now we need to explore how it does that, and what it means."


'/>"/>

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Book on little-known species and conservation provides guidance to managers and others
2. MSU researcher uses grant to study little-known but largely useful microbes
3. Protein chatter linked to cancer activation
4. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
5. Researchers identify proteins involved in new neurodegenerative syndrome
6. Low levels of key protein may indicate pancreatic cancer risk
7. Structure of 450 million year old protein reveals evolutions steps
8. Scientists retrace evolution with first atomic structure of an ancient protein
9. Specific brain protein required for nerve cell connections to form and function
10. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
11. Interacting protein theory awaits test from new neutron analysis tools
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Little-known protein found to be key player
(Date:5/20/2015)... 20, 2015 ... announced the addition of the  "5-year ... Recognition Market"  report to their offering.  ... service analyses trends in the iris ... commercial sectors, globally. Despite hardware pricing ...
(Date:5/18/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... the risk of acquiring HIV in young African men, according ... professor of epidemiology Robert Bailey. , The study is published ... , Researchers conducted a clinical trial enrolling 2,784 HIV negative, ... Kenya, where an estimated 26 percent of uncircumcised men are ...
... Some day, heart attack survivors might have a patch of ... died during their attack. Children born with defective heart valves ... than being replaced every few years. And people with clogged ... of a factory-made one. , These possibilities are all within ...
... about bird flu, involving the use of a mathematical ... might be the best way to deal with an ... triggered a worldwide human epidemic yet because it rarely ... it would take 6-8 months to develop a vaccine ...
Cached Biology News:Circumcision: A proven strategy to prevent HIV 2Engineering the heart piece by piece 2Engineering the heart piece by piece 3Engineering the heart piece by piece 4
(Date:6/2/2015)... 2, 2015   Hospira, Inc. (NYSE: ... that its partner, Celltrion – a global biopharmaceutical company – ... Surveillance Agency in Brazil – ... for use in Brazil . The ... and sells biosimilar infliximab in 26 European countries and ...
(Date:6/2/2015)... June 02, 2015 “Stem Cell Therapy to ... mainstream, and it is used often as an adjunct to ... practitioners are not yet aware or comfortable enough with the ... is most often reserved for the last resort cases - ... can barely lift a paw to get around. It is ...
(Date:6/2/2015)... June 2, 2015   Intrexon Corporation ... biology, announced today the appointment of Olivier ... Consumer Sector.  Mr. Jarry will lead the expansion ... and applications for consumer markets.  ... of experience in leading global life sciences and ...
(Date:6/2/2015)... 2, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering and developing innovative therapies primarily ... today announced that Dr. Pamela Pavco , ... the 23 rd World Congress of ... include in-depth presentations by world-class clinicians and/or ...
Breaking Biology Technology:ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 3Intrexon Announces New Sector Leader 2Intrexon Announces New Sector Leader 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4
... June 18 HemoCue(R) AB, a,global point-of-care diagnostic ... Incorporated (NYSE: DGX ), today announced,that its ... point-of-care,test for screening for, diagnosing and monitoring microalbuminuria ... Food and Drug Administration (FDA). With,the FDA CLIA ...
... ARUP Laboratories, a national,clinical and anatomic pathology reference ... development, announced today that it has,entered into a ... nationwide network affiliation and a principal provider of,business ... effective June 17, 2008, offers special pricing to ...
... 18 Medarex, Inc.,(Nasdaq: MEDX ) announced today ... Annual Healthcare Conference at 11:15 a.m. Eastern Time on,Wednesday, ... and will be,available in the Investor Relations section of ... of the presentation will be available,following the event., ...
Cached Biology Technology:HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 2HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 3HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 4HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 5ARUP Laboratories Partners With Pathology Service Associates 2ARUP Laboratories Partners With Pathology Service Associates 3Medarex to Present at the Jefferies Second Annual Healthcare Conference 2
HSPBP1 Antibody...
golgi reassembly stacking protein 2, 55kDa...
...
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Biology Products: